Informa Connect

2 weeks ago | informaconnect.com | Brandy Fidler

Managing and auditing healthcare professional (HCP) engagement expenses effectively is essential for regulatory compliance, yet traditional methods used for this function are becoming increasingly inadequate, according to qordata. A recent white paper by qordata, titled “How AI is Reshaping HCP Expense Auditing,” examined the challenges companies face with HCP expense auditing and addresses how AI is changing these processes for compliance professionals.

2 weeks ago | informaconnect.com | Brandy Fidler

Pharmaceutical field-facing interacting roles have evolved far beyond the traditional sales representative roles. According to panelists at the Pharmaceutical Compliance Congress, companies now deploy an array of specialized field professionals including field reimbursement managers (FRMs) and thought leader liaisons (TLLs).

2 weeks ago | informaconnect.com | Brandy Fidler

Speaker programs, government price reporting and patient support programs are among the top compliance risk areas in M&A transactions, experts say. At the recent Pharmaceutical Compliance Congress, panelists during the “Managing M&A and Licensing Agreements” session identified these key risk areas requiring careful examination.

3 weeks ago | informaconnect.com | Brandy Fidler

In a recent webinar, industry experts shared insights on how digital patient engagement strategies are transforming patient support programs. The presentation, featuring Oliver Dunford, vice president of life sciences at Relay Network, and Angela Cornacchia, director of patient experience, patient access services, at Alkermes, revealed data from over 500,000 patient interactions across 26 specialty and rare disease brands.

3 weeks ago | informaconnect.com | Gareth Macdonald

Interactive response technologies (IRTs) are an ideal fit for cell and gene therapy trials, according to IQVIA, which says sponsors and CROs increasingly view software suppliers as partners. The health data and research services firm shared its view on IRT last week, arguing in a blog post that such systems are ideal for the unique, highly complex logistical challenges involved in cell and gene therapy (CGT) clinical studies.